Contact
searchSearch
HMP Global

Peripheral Arterial Disease

PAD and Heart Month
PAD Awareness
PAD Pulse Alliance Urges Screening for Disease Most Don’t Know They Have During American Heart Month
02/03/2025
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught...
02/03/2025
Cath Lab Digest
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
Dr Halena
LINC 2025
“Yes, you can always cross”: Simplified Retrograde Access for Superficial Femoral Artery Occlusions
01/29/2025
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations,...
01/29/2025
Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Interview
The Economic Costs and Patient Consequences of Amputation as a Treatment for Critical Limb Ischemia
09/19/2024
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and...
09/19/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
Ramon L. Varcoe, MBBS, MS, PhD
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
Thomas Zeller, MD, PhD
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Zola N'Dandu, MD
AMP 2024
Pooled Analysis of the DETOUR System; Risk Factors in CLI Patients That May Require DVA
09/17/2024
Zola N'Dandu, MD
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu...
09/17/2024
Vascular Disease Management
Chronic Limb-Threatening Ischemia (CLTI)
Treating a CTO of the SFA Using Auryon Laser Atherectomy in a CLTI Patient
08/31/2024
Nader Chadda, MD, FACC; IIyas Chadda
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man...
08/31/2024
Cath Lab Digest

PAD and Heart Month
PAD Awareness
PAD Pulse Alliance Urges Screening for Disease Most Don’t Know They Have During American Heart Month
02/03/2025
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught until a patient is at risk of losing a limb. While treatment options have significantly advanced, it’s critical that more people know the signs and symptoms of PAD so they can seek treatment early, saving their...
“Too often, PAD isn’t caught...
02/03/2025
Cath Lab Digest
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
Dr Halena
LINC 2025
“Yes, you can always cross”: Simplified Retrograde Access for Superficial Femoral Artery Occlusions
01/29/2025
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations, Grzegorz Halena, MD, tackled simplified retrograde access for superficial femoral artery (SFA) occlusions, taking the position that they are always possible to cross.
In his LINC 2025 presentations,...
01/29/2025
Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Interview
The Economic Costs and Patient Consequences of Amputation as a Treatment for Critical Limb Ischemia
09/19/2024
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and cofounder of The Yost Group, spoke with VDM about her AMP 2024 presentation on the consequences of amputation as a treatment for patients with CLI.
Mary Yost, MBA, president and...
09/19/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
Ramon L. Varcoe, MBBS, MS, PhD
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
Thomas Zeller, MD, PhD
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Zola N'Dandu, MD
AMP 2024
Pooled Analysis of the DETOUR System; Risk Factors in CLI Patients That May Require DVA
09/17/2024
Zola N'Dandu, MD
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu...
09/17/2024
Vascular Disease Management
Chronic Limb-Threatening Ischemia (CLTI)
Treating a CTO of the SFA Using Auryon Laser Atherectomy in a CLTI Patient
08/31/2024
Nader Chadda, MD, FACC; IIyas Chadda
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The...
The patient is a 77-year-old man...
08/31/2024
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use